Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -23.46-24.787.6324.25407.44

What is the latest Core EBITDA Growth ratio of BALAXI PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of BALAXI PHARMACEUTICALS is -23.46 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-23.46
Mar2024-24.78
Mar20237.63
Mar202224.25
Mar2021407.44

How is Core EBITDA Growth of BALAXI PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -23.46
Negative
Mar2024 -24.78
Negative
Mar2023 7.63
-68.54
Mar2022 24.25
-94.05
Mar2021 407.44 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹231.0 Cr -2.6% -4.1% -53.6% Stock Analytics
ADANI ENTERPRISES ₹273,552.0 Cr -4.5% -6.8% -21.5% Stock Analytics
REDINGTON ₹22,823.9 Cr 15% 6.1% 49.6% Stock Analytics
LLOYDS ENTERPRISES ₹10,127.2 Cr -3.1% -3.9% 47.7% Stock Analytics
MMTC ₹9,801.0 Cr -4.9% -4.4% -17% Stock Analytics
HONASA CONSUMER ₹8,900.5 Cr -3.8% -7.2% -30% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-2.6%

-4.1%

-53.6%

SENSEX

-1.4%

1.7%

4.8%


You may also like the below Video Courses